Fennec Pharmaceuticals Inc. (FENC)
NASDAQ: FENC · Real-Time Price · USD
5.77
-0.14 (-2.37%)
Mar 30, 2026, 4:00 PM EDT - Market closed
Fennec Pharmaceuticals Revenue
In the year 2025, Fennec Pharmaceuticals had annual revenue of $44.64M, down -6.09%. Fennec Pharmaceuticals had revenue of $13.78M in the quarter ending December 31, 2025, with 73.84% growth.
Revenue (ttm)
$44.64M
Revenue Growth
-6.09%
P/S Ratio
4.46
Revenue / Employee
$1,395,063
Employees
35
Market Cap
198.92M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 44.64M | -2.90M | -6.09% |
| Dec 31, 2024 | 47.54M | 26.29M | 123.69% |
| Dec 31, 2023 | 21.25M | 19.72M | 1,284.50% |
| Dec 31, 2022 | 1.54M | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Keros Therapeutics | 244.06M |
| Arcturus Therapeutics Holdings | 82.03M |
| Compugen | 72.76M |
| Editas Medicine | 40.52M |
| MediWound | 16.96M |
| Camp4 Therapeutics | 3.50M |
FENC News
- 6 days ago - Fennec Pharmaceuticals Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses - Newsfile Corp
- 6 days ago - Fennec Pharmaceuticals Inc. (FENC) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 6 days ago - Fennec Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 7 days ago - Fennec Pharmaceuticals Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call - Benzinga
- 12 days ago - Fennec Pharmaceuticals to Report Full Year and Fourth Quarter 2025 Financial Results on March 24, 2026 - GlobeNewsWire
- 26 days ago - Fennec Pharmaceuticals Announces Clinical Research Collaboration with Tampa General Hospital Cancer Institute - GlobeNewsWire
- 3 months ago - Southpoint holdings in Fennec Pharmaceuticals Inc. (TSX: FENC) - GlobeNewsWire
- 3 months ago - Fennec Pharmaceuticals: A Compelling Single-Asset Growth Story For 2026 - Seeking Alpha